Loading
Latest filing published 09 Aug 2016 for Avapecia Life Sciences Corp., €138.
No signal scores available.
Only one filing by Peter Micheal Neweduk is known so far (9 August 2016): an open-market purchase, €138, in Avapecia Life Sciences Corp. That is too little to draw conclusions. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration